Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Sarah Horn

Contact

horns@uthscsa.edu

Departments & Divisions

Research

Research profile

Clinical

Provider profile

Sarah Horn

Assistant Professor/Clinical

Sarah Horn, MD is an Assistant Professor of Neurology who specializes in the evaluation and treatment of patients with movement disorders, including botulinum toxin injections and management of deep brain stimulators. She began exploring science in a basic context in college, working as a summer research assistant in the biochemistry laboratory at Trinity University. She then attended medical school at the McGovern Medical School at UTHealth, where the neurologists’ craft of making bedside diagnoses, coupled with the anticipation of upcoming major scientific breakthroughs in the field, inspired her to become a movement disorders specialist. As an Edmond J. Safra Fellow in Movement Disorders at the University of Pennsylvania, she participated in multiple clinical research projects investigating patients’ experience with Parkinson’s disease. With an interest in comparative effectiveness research, she retrospectively analyzed the effectiveness of quetiapine versus pimavanserin for psychosis associated with Parkinson’s disease and dementia with Lewy bodies and currently is principal investigator for an actively enrolling pragmatic clinical trial funded by the Alzheimer’s Association studying the long term effects of these medications in a real-world setting. She has served as site sub-investigator and principal investigator for numerous clinical trials and was selected as a Parkinson Study Group investigator. She sees patients through the Parkinson’s Disease and Movement Disorders Program, is a site investigator for multiple clinical trials, is program director of the movement disorders fellowship, remains active in teaching medical students and neurology residents, and has multiple ongoing clinical research projects designed to address unknowns encountered in clinical practice.

  • Professional Background

    Education

    • 2013 - MD - Medicine - McGovern Medical School at UT Health, Houston, TX
    • 2009 - BS - Biochemistry and Molecular Biology - Trinity University, San Antonio, TX

    Training

    • 2019 - Fellowship - Movement Disorder - Pennsylvania Hosp, Perelman School of Medicine Univ of Pennsylvania, Philadelphia, PA
    • 2017 - Residency - Neurology - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
    • 2017 - Certificate - Clinical Research - Perelman School of Med Univ of Pennsylvania Ctr for Clin Epi and Bio, Philadelphia,PA
    • 2014 - Internship - Internal Medicine - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Highlights

    Holder appointment of the Maj. Gen (USA Ret.) Joe and Patty Robles Professorship in Parkinson’s Disease Research
    Bexar County Medical Society 2022 Women Leaders in Medicine, Colette M. Kohler Award
    Top Doctors In Texas Rising Stars, Texas Monthly, July 2022
    Top Doctors In Texas Rising Stars, Texas Monthly, July 2021
    Outstanding Women in Medicine, Scene in S.A., Spring 2021
    Best Doctors in San Antonio, 2019

    Appointments

    • 09/2019 - Assistant Professor/Clinical - UT Health San Antonio, Department of Neurology, San Antonio, TX

  • Instruction & Training

    • 09/2019 - present, Neurology Core Clerkship, UT Health Science Center San Antonio
    • 01/2018 - present, Differential Diagnosis, Perelman School of Medicine University of Pennsylvania
    • 01/2018 - present, Introduction To Evidence-Based Practice, Perelman School of Medicine University of Pennsylvania

  • Research & Grants

    Research profile

  • Service

    Department

    10/2019-Present Associate Program Director - Movement Disorders Fellowship Program

    Global

    01/2019-12/2019 International NPJ Parkinson‘s disease Ad Hoc Reviewer
    01/2019-12/2019 International PLOS ONE Ad Hoc Reviewer

  • Publications

      Abstract

      Horn SK, Wu S ,Dai Y, Cubillos F, Dahodwala N. Differences In Patient Demographics Drive Gender Disparities In Caregiving In Parkinson‘s Disease 2019 Sep. (Poster session, MDS International‘s Congress in Nice, France).

      Horn SK, Dahodwala N. Pimavanserin Versus Quetiapine For The Treatment of Psychosis In Parkinson‘s Disease and Dementia With Lewy bodies 2019 May. (Poster session at the American Academy of Neurology, Philadelphia, PA (Co-Presenter)

      Nwadiogbu C, Pavon M, Horn SK, Dahodwala N. Barriers and Characteristics of Caregiving Preparedness in Parkinson‘s disease: A Qualitative Approach 2019 May. (Presented at the American Academy of Neurology, Philadelphia, PA (Co-presenter)

      Vitt J, Hamedani A, Horn SK, Gannon K, Price R, Greene M. Slowly Progressive, Acquired Hemicerebral Atrophy Secondary to Chronic Internal Carotid Vascular Disease Mimicking Neurodegenerative Disease 2019 May. (Presented at the American Academy of Neurology, Philadelphia, PA (Co-Presenter)

      Horn SK, Coughlin D, Chou J, Wang F, Stacy M, Dolhun R, Kopil C, Amondikar N, Deik A, Sarva H . Patient and Provider Experiences and Attitudes Toward Rytary 2018 Oct. (Presented at the International Congress of Parkinson‘s Disease and Movement Disorders)

       

      Book Chapter

      Horn S, Winland-Brown, J. Primary Care: The Art and Science of Advanced Practice Nursing, 5th edition In: Chapter 8 Degenerative Disorders. B. Porter & D. Thomas (Eds.); 2018

      Winland-Brown J, Horn SK. Primary Care: The Art and Science of Advanced Practice Nursing, 5th edition In: Chapter 10 Infectious and Inflammatory Disorders. B. Porter & D. Thomas (Eds.); 2018

      Winland-Brown J, Horn SK. Primary Care: The Art and Science of Advanced Practice Nursing, 5th edition In: Chapter 7 Seizure Disorders. B. Porter & D. Thomas (Eds.); 2018

      Horn SM, Winland-Brown J. Primary Care: The Art and Science of Advanced Practice Nursing, 5th edition In: Chapter 9 Cerebrovascular Disease. B. Porter & D. Thomas (Eds.); 2018

       

      Journal Article

      Vitt, J, Hamedani, A, Horn SK, Gannon K, Price R, Greene M. Acquired Hemicerebral Atrophy Secondary to Chronic Internal Carotid Steno-Occlusive Disease: A Case Series. The Neurohospitalist 2020 Jan;10(1):38-42

      Horn SK, Richardsons H, Xie S, Weintraub D, Dahodwala N. Pimavanserin Versus Quetiapine For The Treatment of Psychosis In Parkinson's Disease and Dementia With Lewy Bodies Parkinsonism & Related Disorders 2019 Dec;69:119-124

       

  • Clinical

    Provider profile

    Board Certifications

    • 2017 - American Board of Psychiatry and Neurology